IL299105B2 - Pharmacologically active history of pyrazolo-trizine and/or pyrazolo-pyrimidine - Google Patents
Pharmacologically active history of pyrazolo-trizine and/or pyrazolo-pyrimidineInfo
- Publication number
- IL299105B2 IL299105B2 IL299105A IL29910522A IL299105B2 IL 299105 B2 IL299105 B2 IL 299105B2 IL 299105 A IL299105 A IL 299105A IL 29910522 A IL29910522 A IL 29910522A IL 299105 B2 IL299105 B2 IL 299105B2
- Authority
- IL
- Israel
- Prior art keywords
- occurrence
- group
- cancer
- alkyl
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862656041P | 2018-04-11 | 2018-04-11 | |
| PCT/EP2019/059289 WO2019197546A1 (en) | 2018-04-11 | 2019-04-11 | Pharmaceutically active pyrazolo-triazine and/or pyrazolo-pyrimidine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL299105A IL299105A (en) | 2023-02-01 |
| IL299105B1 IL299105B1 (en) | 2023-10-01 |
| IL299105B2 true IL299105B2 (en) | 2024-02-01 |
Family
ID=66334384
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL299105A IL299105B2 (en) | 2018-04-11 | 2019-04-11 | Pharmacologically active history of pyrazolo-trizine and/or pyrazolo-pyrimidine |
| IL277694A IL277694A (en) | 2018-04-11 | 2020-09-30 | Pharmacologically active history of pyrazolo-trizine and/or pyrazolo-pyrimidine |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL277694A IL277694A (en) | 2018-04-11 | 2020-09-30 | Pharmacologically active history of pyrazolo-trizine and/or pyrazolo-pyrimidine |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11858937B2 (enExample) |
| EP (1) | EP3774809A1 (enExample) |
| JP (2) | JP7406501B2 (enExample) |
| KR (1) | KR102966358B1 (enExample) |
| CN (1) | CN112334471A (enExample) |
| AU (1) | AU2019250504B2 (enExample) |
| BR (1) | BR112020020645A2 (enExample) |
| CA (1) | CA3095426A1 (enExample) |
| IL (2) | IL299105B2 (enExample) |
| MX (1) | MX2020010563A (enExample) |
| MY (1) | MY207194A (enExample) |
| PH (1) | PH12020551638A1 (enExample) |
| SG (1) | SG11202009466UA (enExample) |
| WO (1) | WO2019197546A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202146416A (zh) * | 2019-12-11 | 2021-12-16 | 德商拜耳廠股份有限公司 | 吡唑并三𠯤 |
| GB201918541D0 (en) | 2019-12-16 | 2020-01-29 | Carrick Therapeutics Ltd | Therapeutic compounds and their use |
| EP4255909A1 (en) * | 2020-12-02 | 2023-10-11 | Qurient Co. Ltd. | Compounds having cyclin-dependent kinase(cdk)-inhibitory function |
| WO2022248682A1 (en) * | 2021-05-28 | 2022-12-01 | Qurient Co., Ltd. | Compounds for degradation of cyclin-dependent kinase 7 (cdk7) |
| US20250042903A1 (en) * | 2021-06-17 | 2025-02-06 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Triazine inhibitors of cyclin-dependent kinases |
| WO2023175173A1 (en) * | 2022-03-18 | 2023-09-21 | Qurient Co., Ltd. | Cdk7 inhibitors for antiviral treatment |
| US20260041693A1 (en) | 2022-08-05 | 2026-02-12 | Qurient Co., Ltd. | Combination therapy of cdk7 inhibitors with other anti-cancer therapies |
| KR20240095030A (ko) | 2022-12-15 | 2024-06-25 | 부산대학교 산학협력단 | 간과 신장의 염증 및 섬유화 치료 효과가 있는 신규 트리아진 유도체 및 이의 제조방법 |
| CN120752238A (zh) * | 2023-02-20 | 2025-10-03 | 江苏正大丰海制药有限公司 | 作为cdk7激酶抑制剂的杂芳环化合物及其制备和应用 |
| CN120712267A (zh) * | 2023-02-21 | 2025-09-26 | 杭州德睿智药科技有限公司 | 作为CDKs抑制剂的新型并杂环类新化合物及其应用 |
| WO2025040170A1 (zh) * | 2023-08-24 | 2025-02-27 | 杭州德睿智药科技有限公司 | 作为CDKs抑制剂的新型并杂环类新化合物及其应用 |
| WO2025162425A1 (zh) * | 2024-02-01 | 2025-08-07 | 广州费米子科技有限责任公司 | 吡唑并嘧啶化合物作为tyk2抑制剂 |
| CN119606955A (zh) * | 2024-11-13 | 2025-03-14 | 南方医科大学 | Txd-174在制备治疗和/或预防黄病毒属病毒感染产品中的应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013128029A1 (en) * | 2012-03-01 | 2013-09-06 | Lead Discovery Center Gmbh | Pharmaceutically active pyrazolo-triazine derivatives |
| WO2013128028A1 (en) * | 2012-03-01 | 2013-09-06 | Lead Discovery Center Gmbh | Pyrazolo - triazine derivatives as selective cyclin- dependent kinase inhinitors |
| WO2015154022A1 (en) * | 2014-04-05 | 2015-10-08 | Syros Pharmaceuticals, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
| WO2016142855A2 (en) * | 2015-03-09 | 2016-09-15 | Aurigene Discovery Technologies Limited | Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US615968A (en) | 1898-12-13 | Apparatus for treating ores | ||
| US8580782B2 (en) | 2002-09-04 | 2013-11-12 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors |
| US8673924B2 (en) | 2002-09-04 | 2014-03-18 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors |
| JP2010529140A (ja) * | 2007-06-05 | 2010-08-26 | エモリー・ユニバーシテイ | サイクリン依存性キナーゼの選択的阻害剤 |
| GB201403093D0 (en) * | 2014-02-21 | 2014-04-09 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| WO2019035866A1 (en) | 2017-08-15 | 2019-02-21 | The Brigham & Women's Hospital, Inc. | COMPOSITIONS AND METHODS FOR TREATING THE TUBEROUS SCLEROSIS COMPLEX |
-
2019
- 2019-04-11 MY MYPI2020005131A patent/MY207194A/en unknown
- 2019-04-11 CN CN201980039675.8A patent/CN112334471A/zh active Pending
- 2019-04-11 KR KR1020207032377A patent/KR102966358B1/ko active Active
- 2019-04-11 US US17/045,009 patent/US11858937B2/en active Active
- 2019-04-11 IL IL299105A patent/IL299105B2/en unknown
- 2019-04-11 SG SG11202009466UA patent/SG11202009466UA/en unknown
- 2019-04-11 MX MX2020010563A patent/MX2020010563A/es unknown
- 2019-04-11 EP EP19720424.1A patent/EP3774809A1/en active Pending
- 2019-04-11 BR BR112020020645-8A patent/BR112020020645A2/pt unknown
- 2019-04-11 AU AU2019250504A patent/AU2019250504B2/en active Active
- 2019-04-11 JP JP2020555188A patent/JP7406501B2/ja active Active
- 2019-04-11 WO PCT/EP2019/059289 patent/WO2019197546A1/en not_active Ceased
- 2019-04-11 CA CA3095426A patent/CA3095426A1/en active Pending
-
2020
- 2020-09-30 IL IL277694A patent/IL277694A/en unknown
- 2020-10-05 PH PH12020551638A patent/PH12020551638A1/en unknown
-
2023
- 2023-08-14 JP JP2023131905A patent/JP2023138859A/ja not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013128029A1 (en) * | 2012-03-01 | 2013-09-06 | Lead Discovery Center Gmbh | Pharmaceutically active pyrazolo-triazine derivatives |
| WO2013128028A1 (en) * | 2012-03-01 | 2013-09-06 | Lead Discovery Center Gmbh | Pyrazolo - triazine derivatives as selective cyclin- dependent kinase inhinitors |
| WO2015154022A1 (en) * | 2014-04-05 | 2015-10-08 | Syros Pharmaceuticals, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
| WO2016142855A2 (en) * | 2015-03-09 | 2016-09-15 | Aurigene Discovery Technologies Limited | Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors |
Also Published As
| Publication number | Publication date |
|---|---|
| BR112020020645A2 (pt) | 2021-01-12 |
| SG11202009466UA (en) | 2020-10-29 |
| CN112334471A (zh) | 2021-02-05 |
| CA3095426A1 (en) | 2019-10-17 |
| AU2019250504B2 (en) | 2023-05-18 |
| JP2023138859A (ja) | 2023-10-02 |
| KR102966358B1 (ko) | 2026-05-15 |
| JP2021521129A (ja) | 2021-08-26 |
| WO2019197546A1 (en) | 2019-10-17 |
| KR20200143429A (ko) | 2020-12-23 |
| MX2020010563A (es) | 2020-10-22 |
| US20210139483A1 (en) | 2021-05-13 |
| IL299105B1 (en) | 2023-10-01 |
| US11858937B2 (en) | 2024-01-02 |
| PH12020551638A1 (en) | 2021-07-26 |
| IL277694A (en) | 2020-11-30 |
| JP7406501B2 (ja) | 2023-12-27 |
| EP3774809A1 (en) | 2021-02-17 |
| MY207194A (en) | 2025-02-05 |
| AU2019250504A1 (en) | 2020-10-15 |
| NZ768400A (en) | 2024-07-05 |
| IL299105A (en) | 2023-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102966358B1 (ko) | 약학적으로 유효한 피라졸로-트리아진 및/또는 피라졸로-피리미딘 유도체 | |
| AU2022241543B2 (en) | 1,2,4-oxadiazole derivatives as immunomodulators | |
| AU2021381437C1 (en) | Novel spiropyrrolidine derived antiviral agents | |
| RU2013128612A (ru) | Соли и кристаллические формы индуцирующего апоптоз агента | |
| JP2021529814A (ja) | 化学化合物 | |
| JP5786147B2 (ja) | 抗炎症薬としてのイミダゾ（４，５−ｂ）ピリジン−６−カルボキサミド | |
| JP2021521129A5 (enExample) | ||
| BR112014021189B1 (pt) | Composto, seu uso para a preparação de uma composição farmacêutica, e, composição farmacêutica contendo o mesmo | |
| JP2021521120A5 (enExample) | ||
| AU2016357927B2 (en) | Macrocyclic broad spectrum antibiotics | |
| CA3187168A1 (en) | Compounds, compositions and methods | |
| CN105916499A (zh) | 12-表-截短侧耳素 | |
| CA3191410A1 (en) | Sulphamoyl urea derivatives containing alkyl-oxacycloalkyl moiety and uses thereof | |
| AU2001288114B2 (en) | Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient | |
| ES2687826T3 (es) | Arilhidrazidas que contienen una fracción de 2-piridona como agentes antibacterianos selectivos | |
| JP2009544756A5 (enExample) | ||
| BRPI0613958A2 (pt) | composto bicìclico, seu uso como inibidor p38 e composição farmacêutica contendo o mesmo | |
| NZ768400B2 (en) | Pharmaceutically active pyrazolo-triazine and/or pyrazolo-pyrimidine derivatives | |
| JP2008504362A (ja) | Ｐ２ｘ７阻害活性をもつ５−［４−（２−ヒドロキシ−エチル）−３，５−ジオキソ−４，５−ジヒドロ−３ｈ−［１，２，４］トリアジン−２−イル］−ベンズアミド誘導体を、トリアジンの４−位において置換されていない誘導体とオキシランをルイス酸の存在下で反応させることにより製造する方法 | |
| NZ768649A (en) | Pyrazolo-triazine and/or pyrazolo-pyrimidine derivatives as selective inhibitor of cyclin dependent kinase | |
| AU2019334574A1 (en) | Inhibitors of glucose transporters (GLUTs) | |
| NZ768649B2 (en) | Pyrazolo-triazine and/or pyrazolo-pyrimidine derivatives as selective inhibitor of cyclin dependent kinase | |
| US20240343732A1 (en) | Compounds for degradation of cyclin-dependent kinase 7(cdk7) | |
| RU2020136911A (ru) | Производные пиразоло-триазина и/или пиразоло-пиримидина в качестве селективного ингибитора циклинзависимой киназы | |
| RU2020135410A (ru) | Фармацевтически активные производные пиразолотриазина и/или пиразолопиримидина |